Anterogen.Co.,Ltd.

₩12,600As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:065660Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (3.31%)
Div yield —
ROE (1.89%)
Biotechnology
Beta (5Y) (0.11)
PE TTM —
TSR TTM (44.12%)
Mkt cap ₩126.1B
ROIC (1.80%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩13,033
3.44%
71.84%
Hold 12|12|7|5|1
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
118.23
115.10
116.87
115.69
1.34%
2.98%
5.95%
(2.90%)
Revenue₩B
6.080
6.199
6.538
6.544
8.49%
10.11%
13.28%
9.65%
Peers (US$92.95M)
Cap (US$)
PE
84.40M
—
Capital
TTM
5Y
10Y
Leveragex
0.620
(0.334)
(0.287)
EBIT/Intx
0.627
1.166
1.026
Own earn%
158.30
105.80
91.55
Sh yield%
9.88
27.02
27.36
Owners
Insiders/Inst%
14.66
50.36
Short interest%
4.55
SBC / revenue%
5.15
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
3–13
$1 testx
0.0
Incr. ROIC%
1